HAE vs KO · P/E 35, rev $1.36B vs P/E 25, rev $47.94B
Haemonetics Corporation (HAE) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the HAE and KO stock pages for the full models.
Not investment advice.